Last reviewed · How we verify
Ondansetron 8mg
Ondansetron 8mg is a Small molecule drug developed by Ain Shams University. It is currently FDA-approved. Also known as: Higher dose Ondanseteron group, Placebo- 4ml of 0.9% IV saline, high ondansetron, Zofran.
Ondansetron 8mg, developed by Ain Shams University, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and patent protection, which helps maintain its competitive edge. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Ondansetron 8mg |
|---|---|
| Also known as | Higher dose Ondanseteron group, Placebo- 4ml of 0.9% IV saline, high ondansetron, Zofran, OND |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase I PK and Safety Study of Ondansetron Inhalation Powder (PHASE1)
- The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities (PHASE2)
- Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile (PHASE2)
- Thoracic Epidural Analgesia With Bilateral Erector Spinae Plane Block in Radical Cystectomy Surgery (NA)
- Ondansetron for the Management of Atrial Fibrillation (PHASE4)
- A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity (PHASE1)
- the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery (PHASE4)
- Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ondansetron 8mg CI brief — competitive landscape report
- Ondansetron 8mg updates RSS · CI watch RSS
- Ain Shams University portfolio CI
Frequently asked questions about Ondansetron 8mg
What is Ondansetron 8mg?
Who makes Ondansetron 8mg?
Is Ondansetron 8mg also known as anything else?
What development phase is Ondansetron 8mg in?
Related
- Manufacturer: Ain Shams University — full pipeline
- Also known as: Higher dose Ondanseteron group, Placebo- 4ml of 0.9% IV saline, high ondansetron, Zofran, OND
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing